Bhatt, Ravi R. http://orcid.org/0000-0003-2498-8888
Gupta, Arpana http://orcid.org/0000-0002-1669-9624
Labus, Jennifer S.
Liu, Cathy
Vora, Priten P.
Jean Stains,
Naliboff, Bruce D.
Mayer, Emeran A. http://orcid.org/0000-0003-3923-3349
Funding for this research was provided by:
National Science Foundation (NSF GRFP 2020290241)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (P30-DK04130, R01DK048351-19)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Article History
Received: 11 February 2021
Revised: 19 October 2021
Accepted: 20 October 2021
First Online: 24 November 2021
Competing interests
: Emeran A. Mayer, MD is a scientific advisory board member of Danone, Axial Biotherapeutics, Viome, Amare, Mahana Therapeutics, Pendulum, Bloom Biosciences and APC Microbiome Ireland. No other authors have no conflicts of interest to disclose.